Explore more publications!

Press Releases

Basilea reports presentation of new data for fosmanogepix, isavuconazole (Cresemba®) and ceftobiprole (Zevtera®) at ESCMID Global 2025
OilXCoin's Prospectus Secures First Regulatory Approval For A Very Unique Security Token Backed by Oil & Gas
argenx Announces European Commission Approval of VYVGART Subcutaneous Injection for Chronic Inflammatory Demyelinating Polyneuropathy
Young experts strengthen professional skills in field of peace and security at OSCE training course

Young experts strengthen professional skills in field of peace and security at OSCE training course

Dental Implants Market worth US$18.79 billion by 2030 with 8.4% CAGR | MarketsandMarkets™.
ThinkCareBelieve: Week 43 of America's Climb into the Golden Age
European Commission Approves Duvyzat for the Treatment of Duchenne Muscular Dystrophy
Legacy Network Powers Up Education With Major Blockchain Move – $LGCT Set To Become Global Currency Of Learning
Ligand Reports First Quarter 2025 Financial Results
Introducing Obyte City: A Community Space to Find Neighbors and Earn Rewards
Radiance Biopharma Enters Exclusive License For ROR-1 Targeted Antibody Drug Conjugate
CariPower Becomes First Order Provider Chosen by Obyte’s Decentralized Governance
argenx Announces Positive CHMP Opinion for VYVGART (efgartigimod alfa) Subcutaneous Injection for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Leqembi®∇ (lecanemab) is the First Medicine that Slows Progression of Early Alzheimer’s Disease to be Authorized in the European Union
Obyte Welcomes CariPower Candidacy as a New Order Provider
bonyf AG receives the EU-MDR Certification Class IIa for PerioCream
Valneva’s Chikungunya Vaccine IXCHIQ® Now Authorized in EU for Adolescents Aged 12 and Above
Ligand Reports Fourth Quarter and Full Year 2024 Financial Results
Global Digital Dentistry Market Report: Projected Growth from USD 4.60 Billion in 2024 to USD 9.22 Billion by 2032
InflaRx Reports Full Year 2024 Results and Highlights Key Achievements and Expected Milestones

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions